These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15971371)

  • 1. Intersecting discourses: MMR vaccine and BSE.
    Wilson C
    Sci Cult (Lond); 2004 Mar; 13(1):75-88. PubMed ID: 15971371
    [No Abstract]   [Full Text] [Related]  

  • 2. Childhood lichen planus after simultaneous measles-mumps-rubella and diphtheria-tetanus-pertussis-polio vaccinations.
    Tasanen K; Renko M; Kandelberg P; Herva R; Oikarinen A
    Br J Dermatol; 2008 Mar; 158(3):646-8. PubMed ID: 18081897
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety concerns regarding combination vaccines: the experience in Japan.
    Andreae MC; Freed GL; Katz SL
    Vaccine; 2004 Sep; 22(29-30):3911-6. PubMed ID: 15364439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study.
    Ray P; Hayward J; Michelson D; Lewis E; Schwalbe J; Black S; Shinefield H; Marcy M; Huff K; Ward J; Mullooly J; Chen R; Davis R;
    Pediatr Infect Dis J; 2006 Sep; 25(9):768-73. PubMed ID: 16940831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misled and confused? Telling the public about MMR vaccine safety. Measles, mumps, and rubella.
    Clements CJ; Ratzan S
    J Med Ethics; 2003 Feb; 29(1):22-6. PubMed ID: 12569190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infant with febrile convulsions/incidental convulsions in the history: how does one proceed with diphtheria-pertussis-tetanus (DPT) and mumps-measles-rubella (MMR) preventive vaccination?].
    Wiersbitzky S; Bruns R; Burtzlaff C
    Kinderarztl Prax; 1993 Nov; 61(9):339-40. PubMed ID: 8114462
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of the Australian Childhood Immunisation Register for vaccine safety data linkage.
    Gold M; Dugdale S; Woodman RJ; McCaul KA
    Vaccine; 2010 Jun; 28(26):4308-11. PubMed ID: 20430123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Has the UK government lost the battle over MMR?
    Bellaby P
    BMJ; 2005 Mar; 330(7491):552-3. PubMed ID: 15760974
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
    Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
    Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.
    Heijstek MW; van Gageldonk PG; Berbers GA; Wulffraat NM
    Ann Rheum Dis; 2012 Jun; 71(6):948-54. PubMed ID: 22172491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gianotti-Crosti syndrome after childhood vaccination.
    Retrouvey M; Koch LH; Williams JV
    Pediatr Dermatol; 2012; 29(5):666-8. PubMed ID: 22352961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines.
    Deforest A; Long SS; Lischner HW; Girone JA; Clark JL; Srinivasan R; Maguire TG; Diamond SA; Schiller RP; Rothstein EP
    Pediatrics; 1988 Feb; 81(2):237-46. PubMed ID: 3340474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transverse myelitis after vaccination.
    Zanoni G; Nguyen TM; Destefani E; Masala L; Nardelli E; Tridente G
    Eur J Neurol; 2002 Nov; 9(6):696-7. PubMed ID: 12453095
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of vaccinations on seizure risk and disease course in Dravet syndrome.
    Verbeek NE; van der Maas NA; Sonsma AC; Ippel E; Vermeer-de Bondt PE; Hagebeuk E; Jansen FE; Geesink HH; Braun KP; de Louw A; Augustijn PB; Neuteboom RF; Schieving JH; Stroink H; Vermeulen RJ; Nicolai J; Brouwer OF; van Kempen M; de Kovel CG; Kemmeren JM; Koeleman BP; Knoers NV; Lindhout D; Gunning WB; Brilstra EH
    Neurology; 2015 Aug; 85(7):596-603. PubMed ID: 26203087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of immune response following immunization with DTP/Td and MMR vaccines in children treated for acute lymphoblastic leukemia.
    Koochakzadeh L; Khosravi MH; Pourakbari B; Hosseinverdi S; Aghamohammadi A; Rezaei N
    Pediatr Hematol Oncol; 2014 Oct; 31(7):656-63. PubMed ID: 25007393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No epidemiological evidence for infant vaccinations to cause allergic disease [Vaccine 2004;22:3375-85].
    da Cunha SS
    Vaccine; 2005 Jun; 23(30):3875. PubMed ID: 15917107
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants.
    Madhi SA; Koen A; Cutland C; Groome M; Santos-Lima E
    Pediatr Infect Dis J; 2013 Aug; 32(8):889-97. PubMed ID: 23538523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad ®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants.
    Deichmann KA; Ferrera G; Tran C; Thomas S; Eymin C; Baudin M
    Vaccine; 2015 May; 33(20):2379-86. PubMed ID: 25765966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced rate of side effects associated with separate administration of MMR and DTaP-Hib-IPV vaccinations.
    Shneyer E; Strulov A; Rosenfeld Y
    Isr Med Assoc J; 2009 Dec; 11(12):735-8. PubMed ID: 20166340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.